1. Home
  2. Browse
  3. Diabetes & Endocrinology

Diabetes & Endocrinology

406 - 420 of 1033 Results
Sort Results:
Article: controversy about the NEW cardiovascular risk calculator January 2014
Article: The Avandia (rosiglitazone) debate will heat up again now that FDA will loosen its restrictions January 2014
Chart: Meds and Choosing Wisely January 2014
PL Voices: Controversy About the New Cardiovascular Risk Calculator January 2014
Commentary: FDA to Lift Some Avandia (Rosiglitazone) Prescribing/Dispensing Restrictions January 2014
PL Voices: Lifestyle Strategies to Lower Cardiovascular Risk January 2014
Chart: Lifestyle Changes to Reduce Cardiovascular Risk January 2014
Article: controversy about what works to prevent contrast-induced nephropathy December 2013
Article: More payers are trying to rein in the use of antipsychotics in patients WITHOUT psychotic disorders December 2013
Article: strategies to improve med adherence December 2013
Patient Education: How to Eat a Heart-Healthy Diet December 2013
PL Voices: Strategies for Improving Medication Adherence December 2013
Article: More payers will recognize the value of pharmacists in improving the quality of patient care November 2013
Article: Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes November 2013
PL Voices: Gliptins and Cardiovascular Risk November 2013